Everyday Health1d
FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over
Semaglutide, the main ingredient in Ozempic and Wegovy, is in ongoing shortage, the FDA says, and compounded versions of these drugs are still permitted. The U.S. Food and Drug Administration (FDA ...
Everyday Health3d
FDA Approves First Medication for Obstructive Sleep Apnea
The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...
Business Insider8d
Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care
Advancing TP-04 (lotilaner ophthalmic gel) for the potential treatment of Ocular Rosacea, another large, underserved eye disease with no FDA-approved therapy; Initiation of Phase 2 study planned for ...
Stockhouse15d
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease
The NDA submission was completed by Sentynl who will be responsible for commercialization upon approval. As described below ... continues to advance with two recent FDA approvals received in Q4 of ...
Staten Island Advance19d
FDA approves first-ever medication for obstructive sleep apnea
The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...
Benzinga.com19d
UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
Also Read: Big Biopharma Trails Behind The Market: JP Morgan’s 2025 Outlook on Eli Lilly, Merck, and More In March 2024, the FDA approved Winrevair (sotatercept-csrk), for injection, 45mg ...
FiercePharma19d
Bristol Myers celebrates 10 years of Opdivo with FDA approval for subcutaneous version
Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in the U.S., the agency has cleared an under-the-skin version of the ...
The American Journal of Managed Care20d
FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors
Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed ...
Monthly Prescribing Reference20d
FDA Approves Opdivo Qvantig, a Subcutaneous Formulation of Nivolumab
Opdivo was previously only available as a solution for intravenous (IV) infusion. The approval of Opdivo Qvantig was supported by data from the randomized, open-label phase 3 CheckMate-67T study ...
Nature20d
2024 FDA approvals
The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...
The Economist20d
China approves the world’s most expensive infrastructure project
On December 25th Xinhua, the state-run news agency, reported that China had approved plans to build the world’s largest hydroelectric dam on the lower reaches of the Yarlung Tsangpo, which flows ...